Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomesby Goldshtein et al
The objective of this stuyd was to examine whether BNT162b2 mRNA vaccination during pregnancy is associated with adverse neonatal and early infant outcomes among the newborns. This large population-based study found no evident differences between newborns of women who received BNT162b2 mRNA vaccination during pregnancy, vs those of women who were not vaccinated, and contributes to current evidence in establishing the safety of prenatal vaccine exposure to the newborns. Interpretation of study findings is limited by the observational design.
23rd February 2022 • comment
The Global Health Network welcomes the highly encouraging news on Pfizer/ Biontech COVID-19 vaccineby Editorial
10th November 2020 • comment